Overview

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique

Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
Despite effective treatments, the majority of patients with multiple sclerosis experience walking impairments to a degree where walking aids or a wheelchair is required. Since 2009, medical treatment of walking impairments has been possible with fampridine, which has proven effective in approximately 40% of the patients. At present, the treatment is offered on the basis of a measurable improved walking function evaluated by simple performance-based walking tests. The treatment is offered on the basis of a measurable improved walking distance. This is shown today using simple performance-based walking tests that are difficult to complete for those MS patients who are without gait function but could still benefit from fampridine treatment. Ultrasound speckle tracking is a non-invasive ultrasound technique, with the potential to measure muscle function, including muscle contractility (through strain). Ultrasound speckle tracking is designed for dynamic cardiac muscular examination, but can in a modified version be used for assessment of the skeletal muscles. The purpose of this project is to use ultrasound speckle tracking to monitor muscle contractility in MS patients receiving vs. not receiving fampridine treatment. Furthermore, to relate these results to biomarkers in blood and urine to examine disease progression and muscle activity.
Phase:
N/A
Details
Lead Sponsor:
University of Southern Denmark
Collaborators:
Fonden for scleroseramte på Fyn
Fonden for scleroseramte paa Fyn
Fonden til Lægevidenskabens Fremme
Lounkær Fonden
Odense University Hospital
Overlægeråds forskningsfond
Region of Southern Denmark
Sygehus Lillebaelt
TH MAIGAARDS EFTF. FRU LILY BENTHINE LUNDS FOND AF 1. JUNI 1978
The Augustinus Foundation, Denmark.
The Danish Multiple Sclerosis Society
The Lily Benthine Lunds Foundation
The Lounkaer Foundation
University of Miami
Treatments:
4-Aminopyridine